Home Applications 203640 Application 203640
Type ANDA
Sponsor APOTEX INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 NILOTINIB HYDROCHLORIDE NILOTINIB HYDROCHLORIDE CAPSULE;ORAL EQ 50MG BASE No No 002 NILOTINIB HYDROCHLORIDE NILOTINIB HYDROCHLORIDE CAPSULE;ORAL EQ 150MG BASE No No 003 NILOTINIB HYDROCHLORIDE NILOTINIB HYDROCHLORIDE CAPSULE;ORAL EQ 200MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203640-001 NILOTINIB HYDROCHLORIDE NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL AB 2024-01-05 A203640-002 NILOTINIB HYDROCHLORIDE NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB 2024-01-05 A203640-003 NILOTINIB HYDROCHLORIDE NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL AB 2024-01-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 54 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL AB 2024-01-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB 2024-01-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL AB 2024-01-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL AB 2024-01-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB 2024-01-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL AB 2024-01-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL AB 2024-01-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB 2024-01-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL AB 2024-01-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL AB 2024-01-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL AB 2024-01-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL AB 2024-01-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL 2024-01-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL 2024-01-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL 2024-01-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL 2024-01-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL 2024-01-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL 2024-01-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL 2024-01-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL 2024-01-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL 2024-01-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL 2024-01-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL 2024-01-05 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL 2024-01-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL 2024-01-05 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL 2024-01-05 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL 2024-01-05 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL 2024-01-05 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203640-002 NILOTINIB HYDROCHLORIDE EQ 150MG BASE CAPSULE / ORAL 2024-01-05 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203640-003 NILOTINIB HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL 2024-01-05 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203640-001 NILOTINIB HYDROCHLORIDE EQ 50MG BASE CAPSULE / ORAL 2024-01-05 1e350fbaab3a…
Observed Orange Book normalized TE history# Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203640-001 PC 2025-11-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203640-002 PC 2025-11-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203640-003 PC 2025-11-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203640-001 PC 2025-11-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203640-002 PC 2025-11-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203640-003 PC 2025-11-19 6a471c1ec25d…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Nilotinib NILOTINIB Apotex Corp. 8283672c-619f-fe60-3d25-040f95ac1440 2026-02-24 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 203640 application number: ANDA203640
Documents# Document, Submission type, Date table Document Submission type Date 77485 ORIG 2024-02-14 71678 ORIG 2022-08-01